FDA recall D-1328-2015

Mylan Institutional LLC · Class I · drug

Product

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.

Reason for recall

Presence of Particulate Matter

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2015-03-18
Report date
2015-08-19
Termination date
2016-06-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Rockford, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1328-2015